G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,595 | -147,559 | -113,910 | -88,638 | -49,192 |
| Depreciation Amortization | 673 | 2,763 | 2,083 | 1,338 | 656 |
| Accounts receivable | -4,931 | -5,406 | -4,833 | -5,099 | -1,927 |
| Other Working Capital | -6,340 | -5,307 | -3,347 | -1,790 | 3,822 |
| Other Operating Activity | 9,140 | 26,889 | 22,019 | 17,448 | 8,457 |
| Operating Cash Flow | $-29,053 | $-128,620 | $-97,988 | $-76,741 | $-38,184 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,910 | -50,023 | -29,661 | N/A | N/A |
| PPE Investments | N/A | -506 | -506 | -506 | N/A |
| Investing Cash Flow | $2,910 | $-50,529 | $-30,167 | $-506 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1 | 52,538 | 145 | 18 | 18 |
| Common Stock Repurchased | -215 | -43 | 0 | 0 | 0 |
| Financing Cash Flow | $-214 | $52,495 | $145 | $18 | $18 |
| Beginning Cash Position | 94,907 | 221,561 | 221,561 | 221,561 | 221,561 |
| End Cash Position | 68,550 | 94,907 | 93,551 | 144,332 | 183,395 |
| Net Cash Flow | $-26,357 | $-126,654 | $-128,010 | $-77,229 | $-38,166 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,053 | -128,620 | -97,988 | -76,741 | -38,184 |
| Capital Expenditure | N/A | -506 | -506 | -506 | N/A |
| Free Cash Flow | -29,053 | -129,126 | -98,494 | -77,247 | -38,184 |